The Role of Splicing Regulators in the Emergence of Treatment-induced Neuroendocrine Prostate Cancer: The Next Generation of Drug Targets?

Fletcher Claire E.

首页> 外文期刊>European urology >The Role of Splicing Regulators in the Emergence of Treatment-induced Neuroendocrine Prostate Cancer: The Next Generation of Drug Targets?

【24h】

The Role of Splicing Regulators in the Emergence of Treatment-induced Neuroendocrine Prostate Cancer: The Next Generation of Drug Targets?

机译：拼接调节剂在治疗诱导的神经内分泌前列腺癌癌症中的作用：下一代药物靶标？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2019年第2期|共3页
作者
Fletcher Claire E.;
展开▼
作者单位

Imperial Coll London Dept Surg &

Canc London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. The Role of Splicing Regulators in the Emergence of Treatment-induced Neuroendocrine Prostate Cancer: The Next Generation of Drug Targets? [J] . Fletcher Claire E. European urology . 2019,第2期

机译：拼接调节剂在治疗诱导的神经内分泌前列腺癌癌症中的作用：下一代药物靶标？
2. Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: A Literature Review [J] . Meera Dhavale, Mohamed K. Abdelaal, A B M Nasibul Alam, Cureus. . 2021,第2期

机译：雄激素受体信号传导和致死神经内分泌前列腺前列腺癌的出现与治疗诱导的雄激素受体抑制：文献综述
3. Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth [J] . Yamamoto Yoshiaki, Loriot Yohann, Beraldi Eliana, Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第7期

机译：靶向雄激素受体及其剪接变体的2.5代反义寡核苷酸抑制耐依杂鲁胺的前列腺癌细胞的生长。
4. Characterization of drug-induced splicing complexity in prostate cancer cell line using long read technology [C] . Xintong Chen, Sander Houten, Kimaada Allette, Pacific Symposium on Biocomputing . 2018

机译：使用长读技术表征前列腺癌细胞中药物诱导的剪接复杂性
5. Development and Characterization of the Next Generation Drug for the Direct Targeting of the FKBP52 Co-Chaperone for the Treatment of Castration Resistant Prostate Cancer [D] . Payan, Ashley Nichole. 2021

机译：下一代药物的开发和表征用于直接靶向FKBP52共伴侣治疗抗阉割前列腺癌
6. Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. EBioMedicine 31 (2018) 267–275 [O] . Yu Gan, Yinan Li, Zhi Long, 2020

机译：更正为在治疗性神经内分泌前列腺癌的发展过程中SRRM4替代Bif-1基因的RNA剪接的作用。 EBioMedicine 31（2018）267–275
7. MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer [O] . En-Chi Hsu, Michelle Shen, Merve Aslan, 2021

机译：MCM2-7综合体是一种新型毒性癌症癌症患者
8. Role of Tumor Microenvironment and the FGF Signaling Axis on Differentiation and Emergence of the Neuroendocrine Phenotype in Prostate Cancer [R] . Evangelou, A. I. 2005

机译：肿瘤微环境和FGF信号轴对前列腺癌神经内分泌表型分化和出现的作用

The Role of Splicing Regulators in the Emergence of Treatment-induced Neuroendocrine Prostate Cancer: The Next Generation of Drug Targets?

著录项

相似文献

相关主题

期刊订阅